Nov 29, 2021 8:45am EST Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202
Nov 17, 2021 4:30pm EST Leading Independent Proxy Advisory Firm, Glass Lewis, Recommends iBio Shareholders Vote “FOR” All Proposals Ahead of Annual Meeting
Nov 15, 2021 4:05pm EST iBio Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update
Nov 15, 2021 1:00pm EST iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors
Nov 08, 2021 4:30pm EST iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021
Oct 26, 2021 8:35am EDT iBio Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting to be Held on December 9
Sep 27, 2021 7:30am EDT iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
Sep 20, 2021 7:30am EDT iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021
